Abstract| Volume 36, SUPPLEMENT 1, e5, March 2018

Preimplantation genetic testing (PGT) for borderline indications – PGT for cancer

      Aim: Inherited cancers have not traditionally been an indication for prenatal diagnosis, as this would lead to pregnancy termination, which may not be justified on the basis of genetic predisposition alone. On the other hand, the possibility of choosing the embryos free of cancer predisposing genes for transfer would obviate the need for pregnancy termination, as only unaffected pregnancies are established. PGT for such conditions is acceptable on ethical grounds because only a limited number of the embryos are selected for transfer.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Reproductive BioMedicine Online
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect